Strong sales and sharply improved margins in 2024 were driven by cost efficiencies, strategic restructuring, and robust growth in Medical Solutions and Materials. Sustainability efforts advanced with validated climate targets and increased renewable energy use.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.